{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-003221","form_type":"8-K","ticker":"ENTA","cik":"0001177648","company_name":"ENANTA PHARMACEUTICALS INC","filed_at":"2022-03-09T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.593116+00:00","generated_at":"2026-06-27T00:18:38.574626+00:00","sec_items":["5.02","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Enanta Pharmaceuticals amends equity plan, adds 1.05M shares for issuance","bullets":["Stockholders approved amendment to 2019 Equity Incentive Plan at March 3, 2022 annual meeting.","Increase of 1,050,000 shares of common stock reserved for issuance under the plan.","Plan as amended filed as Exhibit 10.1."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-003221","json":"https://secwatch.observer/filing/0000950170-22-003221.json","markdown":"https://secwatch.observer/filing/0000950170-22-003221.md","text":"https://secwatch.observer/filing/0000950170-22-003221.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1177648/000095017022003221/0000950170-22-003221-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1177648/000095017022003221/enta-20220303.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T00:18:38.574626+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}